Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Tanja Stocks

Tanja Stocks

Researcher

Tanja Stocks

The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers

Author

  • Josef Fritz
  • Tone Bjørge
  • Gabriele Nagel
  • Jonas Manjer
  • Anders Engeland
  • Christel Häggström
  • Hans Concin
  • Stanley Teleka
  • Steinar Tretli
  • Björn Gylling
  • Alois Lang
  • Pär Stattin
  • Tanja Stocks
  • Hanno Ulmer

Summary, in English

Background: The role of insulin resistance as a mediator in the association of body mass index (BMI) with site-specific cancer risk has, to our knowledge, never been systematically quantified. Methods: Altogether 510 471 individuals from six European cohorts, with a mean age of 43.1 years, were included. We used the triglyceride glucose product (TyG index) as a surrogate measure for insulin resistance. We fitted Cox models, adjusted for relevant confounders, to investigate associations of TyG index with 10 common obesity-related cancers, and quantified the proportion of the effect of BMI mediated through TyG index on the log-transformed hazard ratio (HR) scale. Results: During a median follow-up of 17.2 years, 16 052 individuals developed obesity-related cancers. TyG index was associated with the risk of cancers of the kidney HR per one standard deviation increase 1.13, 95% confidence interval: 1.07 to 1.20], liver (1.13, 1.04 to 1.23), pancreas (1.12, 1.06 to 1.19), colon (1.07, 1.03 to 1.10) and rectum (1.09, 1.04 to 1.14). Substantial proportions of the effect of BMI were mediated by TyG index for cancers of the pancreas (42%), rectum (34%) and colon (20%); smaller proportions for kidney (15%) and liver (11%). Little or no mediation was observed for breast (postmenopausal), endometrial and ovarian cancer. Results were similar for males and females, except for pancreatic cancer where the proportions mediated were 20% and 91%, respectively. Conclusions: The TyG index was associated with increased risk of cancers of the digestive system and substantially mediated the effect of BMI, suggesting that insulin resistance plays a promoting role in the pathogenesis of gastrointestinal cancers.

Department/s

  • Surgery
  • EpiHealth: Epidemiology for Health
  • Biomarkers and epidemiology
  • LUCC: Lund University Cancer Centre
  • EXODIAB: Excellence of Diabetes Research in Sweden

Publishing year

2020

Language

English

Pages

193-204

Publication/Series

International Journal of Epidemiology

Volume

49

Issue

1

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Cancer and Oncology

Keywords

  • Cancer
  • Insulin resistance
  • Longitudinal study
  • Mediation analysis
  • Obesity

Status

Published

Research group

  • Surgery

ISBN/ISSN/Other

  • ISSN: 0300-5771